Clinical Trials in Miami

Showing 8661-8680 of 11,431 trials

Intervention for Newly Diagnosed Youth With HIV

NCT00510237

This study will pilot test an HIV intervention for newly diagnosed youth (diagnosed for less than 15 months) to assess its acceptability and feasibility preliminary to and leading up to a full-scale, randomized trial. The general focus of the intervention is to aid in the psychosocial adjustment of adolescents who have recently been diagnosed with HIV.

HIV

University of North Carolina, Chapel Hill50 participantsStarted Feb 2007

Miami, Florida, United States • Chicago, Illinois, United States • The Bronx, New York, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

NCT00056446

The purpose of this study is to compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread to other organs and whose disease has worsened after treatment with irinotecan.

Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms

Novartis Pharmaceuticals855 participantsStarted Jan 2003

Huntsville, Alabama, United States • Anchorage, Alaska, United States • Tucson, Arizona, United States +248 more locations

Intervention for Newly Diagnosed Youth With HIV

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

Find Trials by Condition in Miami

Engaging Care for HIV-infected Adolescent Females.

Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

A Novel Method to Determine HIV Incidence Among Youth

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care

Treatment De-Intensification and Residual HIV-1 in Youth

HIV Treatment-Readiness Measure (HTRM) Validation

Factors Affecting PrEP Adherence

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes